Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Incyte Corporation
Scientific Title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma